Prof Timothy Price, MBBS, DHlthSc (Med), FRACP - The Queen Elizabeth Hospital - Professor

Prof Timothy Price

MBBS, DHlthSc (Med), FRACP

The Queen Elizabeth Hospital

Professor

Adelaide, SA | Australia

Main Specialties: Oncology

Additional Specialties: Gastrointestinal Medical Oncology

Prof Timothy Price, MBBS, DHlthSc (Med), FRACP - The Queen Elizabeth Hospital - Professor

Prof Timothy Price

MBBS, DHlthSc (Med), FRACP

Introduction

Primary Affiliation: The Queen Elizabeth Hospital - Adelaide, SA , Australia

Specialties:

Additional Specialties:

Publications

58Publications

2902Reads

-Profile Views

2255PubMed Central Citations

Second-line therapy for metastatic colorectal cancer.

Authors:
Timothy J Price

Lancet Oncol 2015 May 12;16(5):476-7. Epub 2015 Apr 12.

Haematology/Oncology Unit, Queen Elizabeth Hospital, Woodville, SA 5011, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70169-5DOI Listing
May 2015
51 Reads
24.690 Impact Factor

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Cancer 2015 Mar 6;121(6):830-5. Epub 2014 Nov 6.

Department Medical Oncology, The Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29129DOI Listing
March 2015
27 Reads
16 Citations
4.890 Impact Factor

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.

Int J Cancer 2014 Aug 24;135(3):731-41. Epub 2014 Jan 24.

Haematology-Oncology Department, Basil Hetzel Institute,The Queen Elizabeth Hospital, Woodville, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28698DOI Listing
August 2014
47 Reads
11 Citations
5.085 Impact Factor

The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17.

Acta Oncol 2014 Jul 5;53(7):877-84. Epub 2014 Feb 5.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney , Sydney, New South Wales , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.879202DOI Listing
July 2014
49 Reads
3 Citations
3.000 Impact Factor

Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.

Clin Colorectal Cancer 2014 Jun 13;13(2):87-93. Epub 2013 Nov 13.

Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, Australia; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2013.11.008DOI Listing
June 2014
58 Reads
10 Citations
2.910 Impact Factor

Can we accurately report PTEN status in advanced colorectal cancer?

BMC Cancer 2014 Feb 25;14:128. Epub 2014 Feb 25.

The Queen Elizabeth Hospital, TQEH Woodville Road, Woodville South, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941793PMC
February 2014
42 Reads
3 Citations
3.362 Impact Factor

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Clin Cancer Res 2014 Feb 11;20(3):744-53. Epub 2013 Nov 11.

Authors' Affiliation: Flinders University, Flinders Centre for Innovation in Cancer; Department of Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0606DOI Listing
February 2014
86 Reads
30 Citations
8.722 Impact Factor

Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer.

Therap Adv Gastroenterol 2014 Jan;7(1):20-37

Department of Medical Oncology, TQEH, Woodville, Woodville Road, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X13498660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871277PMC
January 2014
40 Reads
6 Citations

KRAS G13D Mutation and Sensitivity to Cetuximab or Panitumumab in a Colorectal Cancer Cell Line Model.

Gastrointest Cancer Res 2014 Jan;7(1):23-6

Haematology-Oncology Department Basil Hetzel Institute for Translational Health Research The Queen Elizabeth Hospital Woodville, South Australia, Australia ; Department of Physiology School of Medical Sciences University of Adelaide Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930148PMC
January 2014
67 Reads
17 Citations

Management of gastric cancer in Asia: resource-stratified guidelines.

Lancet Oncol 2013 Nov;14(12):e535-47

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451370436
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70436-4DOI Listing
November 2013
80 Reads
98 Citations
24.690 Impact Factor

Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.

Acta Oncol 2013 Nov;52(8):1699-706

Department of Medical Oncology, The Queen Elizabeth Hospital and University of Adelaide , South Australia , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.831473DOI Listing
November 2013
52 Reads
2 Citations
3.000 Impact Factor

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

Asia Pac J Clin Oncol 2013 Sep 21;9(3):239-48. Epub 2012 Dec 21.

Roche Products Pty Ltd, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12044DOI Listing
September 2013
92 Reads
1.060 Impact Factor

Panitumumab in metastatic colorectal cancer.

Expert Rev Anticancer Ther 2013 Jul 26;13(7):781-93. Epub 2013 Jun 26.

Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2013.811064DOI Listing
July 2013
42 Reads
2.250 Impact Factor

Current opinion on optimal treatment for colorectal cancer.

Expert Rev Anticancer Ther 2013 May;13(5):597-611

The Queen Elizabeth Hospital, Adelaide Colorectal Tumour Group and University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.37DOI Listing
May 2013
54 Reads
10 Citations
2.250 Impact Factor

A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.

Cancer 2013 Feb 18;119(4):722-8. Epub 2012 Sep 18.

Department of Medical Oncology, Flinders Medical Center, Bedford Park, South Australia 5042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27802DOI Listing
February 2013
52 Reads
7 Citations
4.890 Impact Factor

Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapy.

Am J Clin Oncol 2013 Feb;36(1):49-52

Department of Haematology-Oncology, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31823fe40eDOI Listing
February 2013
48 Reads
4 Citations
2.611 Impact Factor

Hepatic encephalopathy associated with cancer or anticancer therapy.

Gastrointest Cancer Res 2013 Jan;6(1):11-6

Department of Medicine Royal Hobart Hospital Tasmania, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597933PMC
January 2013
46 Reads
3 Citations

Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.

Clin Colorectal Cancer 2012 Dec 3;11(4):247-54. Epub 2012 Jul 3.

Department of Medical Oncology, Flinders Medical Centre, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2012.06.004DOI Listing
December 2012
14 Reads
5 Citations
2.910 Impact Factor

A simple, cost-effective and flexible method for processing of snap-frozen tissue to prepare large amounts of intact RNA using laser microdissection.

Biochimie 2012 Dec 10;94(12):2491-7. Epub 2012 Jul 10.

Department of Surgery, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital and Discipline of Medicine, University of Adelaide, 28 Woodville Road, Woodville South, South Australia 5011, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03009084120026
Publisher Site
http://dx.doi.org/10.1016/j.biochi.2012.06.031DOI Listing
December 2012
24 Reads
4 Citations
2.963 Impact Factor

Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.

Cancer Treat Rev 2012 Aug 6;38(5):397-406. Epub 2011 Sep 6.

Department of Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.08.002DOI Listing
August 2012
16 Reads
18 Citations
7.590 Impact Factor

Guillain-Barre syndrome in colorectal cancer.

Asia Pac J Clin Oncol 2012 Jun 12;8(2):205-8. Epub 2012 Mar 12.

Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01493.xDOI Listing
June 2012
44 Reads
2 Citations
1.060 Impact Factor

Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer.

Eur J Cancer 2012 Jun 24;48(9):1293-8. Epub 2011 Nov 24.

Department Medical Oncology, The Queen Elizabeth Hospital, Woodville Rd, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.09.029DOI Listing
June 2012
46 Reads
7 Citations
5.420 Impact Factor

Cetuximab in metastatic colorectal cancer.

Expert Rev Anticancer Ther 2012 May;12(5):555-65

The Queen Elizabeth Hospital and Discipline of Medicine University of Adelaide, 28 Woodville Road, Woodville South, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.25DOI Listing
May 2012
41 Reads
9 Citations
2.250 Impact Factor

Management of advanced gastric cancer.

Expert Rev Gastroenterol Hepatol 2012 Apr;6(2):199-208; quiz 209

Haematology Oncology Unit, The Queen Elizabeth Hospital, Woodville Rd, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/egh.11.103DOI Listing
April 2012
9 Reads
21 Citations
2.550 Impact Factor

"Watchful waiting" for metastatic colorectal cancer, antediluvian or an option to be considered again?

Asia Pac J Clin Oncol 2012 Mar;8(1):10-3

Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01458.xDOI Listing
March 2012
59 Reads
1 Citation
1.060 Impact Factor

Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels.

Clin Proteomics 2011 Dec 5;8(1):16. Epub 2011 Dec 5.

Department of Haematology-Oncology, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1559-0275-8-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259060PMC
December 2011
24 Reads
10 Citations

Contrast induced hyperthyroidism due to iodine excess.

BMJ Case Rep 2009 4;2009. Epub 2009 Nov 4.

The Queen Elizabeth Hospital, Medicine, 28-Woodville Road, Woodville South, Adelaide, South Australia, 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr.06.2009.1982DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028253PMC
November 2011
47 Reads
2 Citations

Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.

Asian Pac J Cancer Prev 2010 ;11(6):1479-85

Epidemiology Branch, Department of Health, Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
July 2011
36 Reads
4 Citations
1.500 Impact Factor

Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study.

BMC Cancer 2011 Jul 26;11:313. Epub 2011 Jul 26.

Adelaide Cancer Center, Level 1, Tennyson Centre, 520 South Road, Kurralta Park, SA 5037, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161034PMC
July 2011
47 Reads
2 Citations
3.362 Impact Factor

South Australian clinical registry for metastatic colorectal cancer.

ANZ J Surg 2011 May 27;81(5):352-7. Epub 2010 Dec 27.

Division of Surgery, Flinders Medical, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1445-2197.2010.05589.xDOI Listing
May 2011
50 Reads
4 Citations
1.120 Impact Factor

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

J Clin Oncol 2011 Apr 7;29(11):1465-71. Epub 2011 Mar 7.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.33.6297DOI Listing
April 2011
109 Reads
113 Citations
18.430 Impact Factor

Reversing Hyperammonemia in Neuroendocrine Tumors.

J Clin Gastroenterol 2010 Sep;44(8):e186-9

Department of Medical Oncology, The Queen Elizabeth Hopsital, Woodville, SA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0b013e3181d96aadDOI Listing
September 2010
50 Reads
2 Citations
3.500 Impact Factor

Epidemiology of neuroendocrine cancers in an Australian population.

Cancer Causes Control 2010 Jun 24;21(6):931-8. Epub 2010 Apr 24.

Epidemiology Branch, South Australian Department of Health, PO Box 6, Rundle Mall, Adelaide, SA, 5000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-010-9519-4DOI Listing
June 2010
38 Reads
2.735 Impact Factor

Antitumor effect of somatostatin analogs in neuroendocrine tumors.

J Clin Oncol 2010 Jan 14;28(3):e41-2; author reply e43-4. Epub 2009 Dec 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.0612DOI Listing
January 2010
34 Reads
2 Citations
18.430 Impact Factor

Pancreatic cancer epidemiology and survival in an Australian population.

Asian Pac J Cancer Prev 2009 Jul-Sep;10(3):369-74

Epidemiology Branch, South Australian Department of Health, Adelaide, South Australia.

View Article

Download full-text PDF

Source
November 2009
13 Reads
3 Citations
1.500 Impact Factor

Selective internal radiation therapy for liver metastases from colorectal cancer.

Cochrane Database Syst Rev 2009 Oct 7(4):CD007045. Epub 2009 Oct 7.

The Queen Elizabeth Hospital, 28 Woodville Road,, Woodville, SA, Australia, 5011.

View Article

Download full-text PDF

Source
https://www.excellusbcbs.com/wps/wcm/connect/ae4de42e-21c2-4
Web Search
http://www.salute.gov.it/imgs/C_17_pagineAree_1202_listaFile
Web Search
http://www.springerlink.com/index/pq17103735582ql5.pdf
Web Search
http://doi.wiley.com/10.1002/14651858.CD007045.pub2
Publisher Site
http://dx.doi.org/10.1002/14651858.CD007045.pub2DOI Listing
October 2009
37 Reads
7 Citations

Fluorouracil-induced hepatic artery spasm preventing yttrium-90 microsphere administration.

Clin Nucl Med 2008 Aug;33(8):528-30

Department of Oncology, The Queen Elizabeth Hospital, Woodville Road, Woodville, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e31817deaebDOI Listing
August 2008
17 Reads
1 Citation
3.931 Impact Factor

Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.

Arch Surg 2008 Mar;143(3):313-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archsurg.2007.65DOI Listing
March 2008
41 Reads
2 Citations
4.930 Impact Factor

A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.

Invest New Drugs 2008 Feb 20;26(1):89-94. Epub 2007 Sep 20.

Cutaneous Oncology Program, University of Colorado Health Sciences Center, PO Box 6510, Mail Stop F703, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-007-9080-5DOI Listing
February 2008
40 Reads
21 Citations
2.920 Impact Factor

Cetuximab for the treatment of colorectal cancer.

N Engl J Med 2007 Nov;357(20):2040-8

Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa071834DOI Listing
November 2007
85 Reads
404 Citations
55.873 Impact Factor

Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.

Leuk Lymphoma 2007 Sep;48(9):1702-11

Department of Oncology, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701509822DOI Listing
September 2007
25 Reads
14 Citations

Successfully improving access and accrual to oncology clinical trials.

Cancer 2007 Apr;109(8):1451-3

Department of Oncology, The Queen Elizabeth Hospital and Lyell McEwin Hospitals, Woodville, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22571DOI Listing
April 2007
35 Reads
2 Citations
4.890 Impact Factor

Reasons for lower survival from non-Hodgkin's lymphoma among older patients.

Asian Pac J Cancer Prev 2004 Jul-Sep;5(3):301-7

Department of Haematology-Oncology Queen Elizabeth Hospital, Adelaide.

View Article

Download full-text PDF

Source
October 2004
12 Reads
1.500 Impact Factor

Top co-authors

Christos S Karapetis
Christos S Karapetis

Flinders University and Flinders Medical Centre

14
Niall C Tebbutt
Niall C Tebbutt

Austin Health

12
Amanda R Townsend
Amanda R Townsend

The Queen Elizabeth Hospital

11
Amanda Townsend
Amanda Townsend

The Queen Elizabeth Hospital

10
David Roder
David Roder

University of South Australia

10
Carol Beeke
Carol Beeke

Department of Surgery

9
John R Zalcberg
John R Zalcberg

School of Public Health and Preventive Medicine

9
Colin Luke
Colin Luke

Epidemiology Branch

8
Jennifer E Hardingham
Jennifer E Hardingham

The Queen Elizabeth Hospital

7
Robert Padbury
Robert Padbury

Flinders University

6